Curing cancer with Cannabidiol?
- CANNABIS OIL, NEWS
- April 24, 2013
In a significant development for Montana’s medical marijuana industry, a district court judge has granted a 60-day preliminary injunction, halting the State of Montana from imposing increased fees on businesses operating multiple marijuana dispensaries. This decision comes as a response to a lawsuit filed by three Montana marijuana businesses challenging the new fee structure introduced
READ MOREIn a significant move, New Zealand’s Medsafe has reclassified cannabidiol (CBD), a medicinal cannabis product, from a prescription-only medicine to a restricted medicine available at pharmacies. This change aligns New Zealand with Australia’s approach, which underwent a similar modification in December 2020. While currently, no CBD products are approved in New Zealand, this reclassification opens
READ MOREIn a bold move against the state’s steep fee hikes, a Florida medical marijuana retailer is taking a stand. The company is contesting a $1.3 million biennial renewal fee—an increase that has been described as ‘exponential’. This fee, endorsed by Governor Ron DeSantis, has sparked a significant debate over the barriers to entry and sustainability
READ MOREIn a significant development, the UK government is reassessing its position on Cannabidiol (CBD) after receiving expert guidance on the compound. CBD, known for its non-psychoactive properties, is one of the numerous cannabinoids found in the cannabis plant. This reevaluation could pave the way for new regulations and an updated framework that may alter the
READ MORE